12 min listen
EULAR 2021 - Day2c
FromRheumnow Podcast
ratings:
Length:
37 minutes
Released:
Jun 4, 2021
Format:
Podcast episode
Description
Iberdomide_ A Novel Drug for Lupus_ Dr. Kathryn Dao
IFN Scores Predict Resistance to Skin Disease During RTX Therapy in Lupus_ Drs. Yusof and Carter
Impact of Pandemic on Rheumatology Training_ Drs. Dao and Young
Impact of RA on Male Fertility_ New Data with Dr. Aurelie Najm, EULAR 2021
MUC5B and Lung Disease in RA_ Dr. Richard Conway
New 2021 GRAPPA Treatment Guidelines for Adult PsO and PsA Patients with Dr. Rachel Tate, EULAR 2021
Predictors of PSA Development in Psoriasis Patients_ Drs. Studenic and Zabotti
IFN Scores Predict Resistance to Skin Disease During RTX Therapy in Lupus_ Drs. Yusof and Carter
Impact of Pandemic on Rheumatology Training_ Drs. Dao and Young
Impact of RA on Male Fertility_ New Data with Dr. Aurelie Najm, EULAR 2021
MUC5B and Lung Disease in RA_ Dr. Richard Conway
New 2021 GRAPPA Treatment Guidelines for Adult PsO and PsA Patients with Dr. Rachel Tate, EULAR 2021
Predictors of PSA Development in Psoriasis Patients_ Drs. Studenic and Zabotti
Released:
Jun 4, 2021
Format:
Podcast episode
Titles in the series (100)
The RheumNow Week in Review - 5 May 2017 by Rheumnow Podcast